Reviva Pharmaceuticals aims to improve schizophrenia treatment with Brilaroxazine, showing promising Phase 3 data but needing funding for a second trial to meet FDA requirements. Reviva should ...

Reviva intends to use the net proceeds from the offering to fund research and development activities and for working capital and other general corporate purposes. The final terms of the offering ...

Reviva Pharmaceuticals announced an underwriting agreement with Citizens JMP Securities for a public offering, raising $18 million through the sale of common stock and warrants. The net proceeds ...

The latest contender is Reviva Pharmaceuticals’ brilaroxazine, which reduced schizophrenia symptoms over a year in a phase 3 trial. Reviva was testing brilaroxazine, an antipsychotic and ...

(RTTNews) - Reviva Pharmaceuticals Holdings, Inc. (RVPH), Monday announced preliminary topline data for the open-label extension portion of the company's ongoing Phase 3 RECOVER study evaluating ...

CUPERTINO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage ...

CUPERTINO, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Reviva Pharmaceuticals (RVPH) announced preliminary topline data for the open-label extension portion of the Company’s ongoing Phase 3 RECOVER study evaluating the long-term safety and ...

Reviva Pharmaceuticals has a 52-week low of $0.60 and a 52-week high of $5.67. The firm has a market capitalization of $92.63 million, a P/E ratio of -2.50 and a beta of -0.02. Institutional ...

Shares of Reviva Pharmaceuticals Holdings tumbled in premarket trading Tuesday after the pharmaceutical company said it was raising $18 million in a public offering of common stock and warrants.

After a pastor took a group of Flat Earthers to Antarctica to prove definitively what shape our planet is, some of the truthers were startled to find that the globe is indeed round. In an ...